| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |